Shire will pay $4.2 billion to buy a drug maker specializing in treatments for rare diseases.
The Food and Drug Administration has approved a new drug for treating epileptic seizures, the agency said Friday.
Drug maker Eisai has launched a new version of a drug used to treat gastroesophageal reflux disease, the company said Friday.
Salix Pharmaceuticals will buy Santarus for $2.6 billion, the drug makers said.
Boehringer Ingelheim SVP managed markets Jeff Huth has been elected by the National Pharmaceutical Council as chairman of the board for 2013-2014, the organization said Friday.
Aisle7 on Thursday announced the launch of Healthnotes Interactions Checker, a next-generation solution simplifying the task of deciding which nutrients positively or negatively interact with the medicines they take.
Noven Pharmaceuticals has launched a new drug for severe hot flashes nationwide, the company said.
Many physicians in Asia say more information on managing Type 2 diabetes is needed, according to a new poll.
On Jan. 23, 2014 Hamacher Resource Group will offer its most popular workshop, "How to Grow Sales Within Independent Pharmacy," at its headquarters here, the company announced Wednesday.
Endo Health Solutions will acquire Canadian drug maker Paladin Labs for $1.6 billion, mostly in shares of stock, Endo said Tuesday.